New York State Common Retirement Fund’s VYNE Therapeutics VYNE Stock Holding History

New York State Common Retirement Fund’s Portfolio VYNE Stock Details VYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-18	Closed	-$1K	–	3532
2021 Q2	$1K	Sell	18 -1,335	-99%	-$106K	﹤0.01%	3480
2021 Q1	$167K	Hold	1,353	–	–	﹤0.01%	2903
2020 Q4	$154K	Hold	1,353	–	–	﹤0.01%	2842
2020 Q3	$162K	Hold	1,353	–	–	﹤0.01%	2741
2020 Q2	$169K	Buy	1,353 +1,304	+2,661%	+$177K	﹤0.01%	2712
2020 Q1	$9K	Hold	49	–	–	﹤0.01%	3150
2019 Q4	$16K	Hold	49	–	–	﹤0.01%	3179
2019 Q3	$16K	Hold	49	–	–	﹤0.01%	3204
2019 Q2	$21K	Hold	49	–	–	﹤0.01%	3221
2019 Q1	$27K	Hold	49	–	–	﹤0.01%	3121
2018 Q4	$14K	Hold	49	–	–	﹤0.01%	3170
2018 Q3	$34K	Hold	49	–	–	﹤0.01%	3123
2018 Q2	$28K	Hold	49	–	–	﹤0.01%	3158
2018 Q1	$132K	Buy	+49	New	+$119K	﹤0.01%	2884

Other funds holding VYNE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

New York State Common Retirement Fund's VYNE Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of VYNE Therapeutics (VYNE) in Q3 2021, closing a stake of 18 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in VYNE in Q1 2018 and held it in 14 quarters. The position peaked at $169K in Q2 2020. 64 funds tracked by Wall St. Rank hold VYNE as of Q3 2021.

New York State Common Retirement Fund reported no remaining VYNE Therapeutics position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 18 VYNE Therapeutics shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in VYNE Therapeutics in Q1 2018 and held it in 14 quarters.
New York State Common Retirement Fund's VYNE Therapeutics position peaked at $169K in Q2 2020.
64 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.